Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles J Sande

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The Journal of Infectious Diseases|November 24, 2012
Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumoniaCharles J Sande, Martin N Mutunga, Graham F Medley, et al.
Science Translational Medicine|March 20, 2020
Priorities for developing respiratory syncytial virus vaccines in different target populationsSimon B Drysdale, Rachael S Barr, Christine S Rollier, et al.
The Journal of Infectious Diseases|September 12, 2012
Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural KenyaCharles N Agoti, Alexander G Mwihuri, Charles J Sande, et al.
Wellcome Open Research|March 26, 2019
Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal KenyaJoyce U Nyiro, Patience K Kiyuka, Martin N Mutunga, et al.
Vaccine|October 16, 2018
Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infectionHannah E Gerretsen, Stefania Capone, Alessandra Vitelli, et al.
Scientific Reports|October 10, 2025
Long-term dynamics of cytomegalovirus-specific antibodies in a longitudinal cohort of children followed up for the first decade of lifeMaureen W Mburu, Mercy S Safari, Timothy O Makori, et al.
Plos One|May 23, 2017
Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, KenyaJoyce U Nyiro, Ivy K Kombe, Charles J Sande, et al.
Vaccine|June 18, 2026
Longitudinal evidence of differential pertussis antibody durability following natural infection among vaccinated children living in contrasting malaria transmission settings in coastal KenyaMercy S Safari, Elijah T Gicheru, Maureen W Mburu, et al.
Nature Communications|May 19, 2019
Airway response to respiratory syncytial virus has incidental antibacterial effectsCharles J Sande, James M Njunge, Joyce Mwongeli Ngoi, et al.
Nature Communications|July 20, 2019
Author Correction: Airway response to respiratory syncytial virus has incidental antibacterial effectsCharles J Sande, James M Njunge, Joyce Mwongeli Ngoi, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|November 24, 2012
Group- and genotype-specific neutralizing antibody responses against respiratory syncytial virus in infants and young children with severe pneumoniaCharles J Sande, Martin N Mutunga, Graham F Medley, et al.
Science Translational Medicine|March 20, 2020
Priorities for developing respiratory syncytial virus vaccines in different target populationsSimon B Drysdale, Rachael S Barr, Christine S Rollier, et al.
The Journal of Infectious Diseases|September 12, 2012
Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural KenyaCharles N Agoti, Alexander G Mwihuri, Charles J Sande, et al.
Wellcome Open Research|March 26, 2019
Agreement between ELISA and plaque reduction neutralisation assay in Detection of respiratory syncytial virus specific antibodies in a birth Cohort from Kilifi, coastal KenyaJoyce U Nyiro, Patience K Kiyuka, Martin N Mutunga, et al.
Vaccine|October 16, 2018
Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infectionHannah E Gerretsen, Stefania Capone, Alessandra Vitelli, et al.
Scientific Reports|October 10, 2025
Long-term dynamics of cytomegalovirus-specific antibodies in a longitudinal cohort of children followed up for the first decade of lifeMaureen W Mburu, Mercy S Safari, Timothy O Makori, et al.
Plos One|May 23, 2017
Defining the vaccination window for respiratory syncytial virus (RSV) using age-seroprevalence data for children in Kilifi, KenyaJoyce U Nyiro, Ivy K Kombe, Charles J Sande, et al.
Vaccine|June 18, 2026
Longitudinal evidence of differential pertussis antibody durability following natural infection among vaccinated children living in contrasting malaria transmission settings in coastal KenyaMercy S Safari, Elijah T Gicheru, Maureen W Mburu, et al.
Nature Communications|May 19, 2019
Airway response to respiratory syncytial virus has incidental antibacterial effectsCharles J Sande, James M Njunge, Joyce Mwongeli Ngoi, et al.
Nature Communications|July 20, 2019
Author Correction: Airway response to respiratory syncytial virus has incidental antibacterial effectsCharles J Sande, James M Njunge, Joyce Mwongeli Ngoi, et al.
Pageof 3